BML Investment Partners Amends 13G/A on Quince Therapeutics (QNCX)

TL;DR

**BML Investment Partners still holds Quince Therapeutics (QNCX) shares, signaling continued institutional interest.**

AI Summary

BML Investment Partners, L.P. filed an amended Schedule 13G/A on February 7, 2024, indicating their ownership of Quince Therapeutics, Inc. (QNCX) common stock as of December 31, 2023. This filing is an amendment to their previous disclosure, confirming their continued significant stake in the company. This matters to investors because BML Investment Partners, L.P. is a substantial institutional holder, and their continued position signals confidence in Quince Therapeutics, Inc.'s future, potentially influencing other investors.

Why It Matters

This filing confirms a significant institutional investor, BML Investment Partners, L.P., maintains a notable stake in Quince Therapeutics, Inc., which can be seen as a vote of confidence in the company's prospects.

Risk Assessment

Risk Level: low — This filing is a routine update from an institutional investor and does not indicate any immediate negative or positive risks.

Analyst Insight

Investors should note that a significant institutional holder, BML Investment Partners, L.P., continues to hold a position in Quince Therapeutics, Inc. This could be a positive signal, but further due diligence on the company's fundamentals and BML's specific investment thesis would be prudent.

Key Players & Entities

• Quince Therapeutics, Inc. (company) — the issuer of the securities
• BML Investment Partners, L.P. (company) — the reporting person and institutional investor
• December 31, 2023 (date) — the date of the event requiring the filing
• $0.001 (dollar_amount) — par value per share of common stock

FAQ

Key Financial Figures

• $0.001 — ame of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securiti

Filing Documents

• qncx13g020724.htm (SC 13G/A) — 79KB
• 0001616824-24-000021.txt ( ) — 81KB

(a)

Item 1(a). Name of Issuer: Quince Therapeutics, Inc.

(b)

Item 1(b). Address of Issuer's Principal Executive Offices: 601 Gateway Boulevard, Suite 1250, South San Francisco, CA 94080

(a)

Item 2(a). Name of Person Filing: BML Investment Partners, L.P

(b)

Item 2(b). Address of Principal Business Office or, if none, Residence: 65 Cedar - Suite 2 Zionsville, IN 46077

(c)

Item 2(c). Citizenship: Delaware

(d)

Item 2(d). Title of Class of Securities: Common Stock, par value $0.001 per share

(e)

Item 2(e). CUSIP Number: 22053A107 Item 3. If This Statement Is Filed Pursuant to Sections 240.13d-1(b) or 240.13d-2(b) or (c), Check Whether the Person Filing Is a(n): (a) Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78o); (b) Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c); (c) Insurance company as defined in Section 3(a)(19) of the Act (15 U.S.C. 78c); (d) Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8); (e) Investment adviser in accordance with Section 240.13d-1(b)(1)(ii)(E); (f) Employee benefit plan or endowment fund in accordance with Section 240.13d-1(b)(1)(ii)(F); (g) Parent holding company or control person in accordance with Section 240.13d-1(b)(1)(ii)(G); (h) Savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); (i) Church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); (j) A non-U.S. institution in accordance with Section 240.13d-1(b)(1)(ii)(J); (k) Group, in accordance with Section 240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with Section 240.13d-1(b)(1)(ii)(J), please specify the type of institution: ____________________________ . Item 4. (a) Amount beneficially owned: 0 (b) Percent of class:0 (c) Number of shares as to which the person has: (i) Sole power to vote or to direct the vote:0 (ii) Shared power to vote or to direct the vote:0 (iii) Sole power to dispose or to direct the disposition of:0 (iv) Shared power to dispose or to direct the disposition of:0 Item 5. If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the f

View Full Filing

View this SC 13G/A filing on SEC EDGAR